The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR’s 2018 Legislative & Regulatory Priorities

The ACR’s 2018 Legislative & Regulatory Priorities

January 5, 2018 • By Kelly Tyrrell

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A recent Politico article outlined the looming agenda facing Congress as 2018 begins: Fund the government, raise the debt ceiling, modify spending caps, address healthcare subsidies, allocate additional funds for disaster relief, and address the status of millions of undocumented young immigrants.1

You Might Also Like
  • The ACR’s 2018 Legislative & Regulatory Priorities
  • The ACR Announces Advocacy Priorities for 2016
  • Top ACR Priorities in 2017 Include Drug Costs, MACRA
Also By This Author
  • Biosimilar Bill Prompts Formation of Nebraska Rheumatology Society

Amid all that activity, the ACR, through its Government Affairs Committee (GAC) and the advocacy work of ACR/ARHP members, continues to advocate for rheumatology professionals and patients.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR’s Priorities
For 2018, the ACR has a long list of legislative and regulatory priorities to address at both the federal and state levels.

MIPS Adjustment/Part B Cost Elimination
Most immediately, says Angus Worthing, MD, FACR, FACP, GAC chair, we need to promote legislation that eliminates MIPS adjustments for Part B drug costs in MACRA, while pressuring the Centers for Medicare and Medicaid Services (CMS) to eliminate Medicare Part B costs or include Part D when calculating physician quality scores under the Merit-Based Incentive Payment System (MIPS) that was set up through MACRA along with an alternative payment model (APM) pathway for Medicare payment.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Under a rule finalized by the CMS in late 2017, items and services—including Part B drugs—furnished by providers on MACRA’s MIPS pathway (which applies to nearly all rheumatologists) would be subject to either a positive or negative adjustment. This is a significant departure from previous policy, which only applied penalties or bonuses associated with quality programs to payment for physician services, not to payments for items such as Part B drugs for which physicians are reimbursed. Estimates project a financial impact in the range of 16–19% for some specialties.2

The ACR also continues to work toward the development of a MACRA alternative payment model (APM) appropriate for rheumatologists.

Drug Prices, Access & PBM Transparency
Drug prices and access to drugs also continue to be a focus of the ACR’s legislative and regulatory efforts, says Dr. Worthing. These are “probably top of the radar screen for most Americans, many members of Congress and the ACR,” he says. “It’s a multifaceted problem that is very frustrating for us in this day and age when we have the tools to diagnose and treat severe disease, and it can be heartbreaking when patients can’t access medications they’re prescribed.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Promoting greater awareness of the role pharmacy benefit managers (PBMs) play in what patients must pay for drugs, and increased transparency of PBM practices, are among the ACR’s priority efforts in 2018 intended to address cost and access.

Pages: 1 2 3 4 | Single Page

Filed Under: Legislation & Advocacy Tagged With: ACR’s 2018 legislative and regulatory priorities, Alternative Payment Model (APM), MIPS adjustments, Part B drug costs, pharmacy benefit managers (PBMs)

You Might Also Like:
  • The ACR’s 2018 Legislative & Regulatory Priorities
  • The ACR Announces Advocacy Priorities for 2016
  • Top ACR Priorities in 2017 Include Drug Costs, MACRA
  • Legislative Priorities in 2007

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)